Encontrados 2 documentos, a visualizar página 1 de 1
Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine in Adults in...
Gouveia, M; Jesus, G; Inês, M; Costa, J; Borges, MThe burden of pneumococcal disease in adults is substantial from a social and economic point of view. This study assessed the cost-effectiveness of the 13-valent pneumococcal conjugate vaccine (PCV13) for the prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults versus "no vaccination" and versus vaccination with the 23-valent pneumococcal polysaccharide vaccine (PPSV23). A Markov mod...
Cost-Effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial F...
Costa, J; Fiorentino, F; Caldeira, D; Inês, M; Lopes Pereira, C; Pinheiro, L; Vaz-Carneiro, A; Borges, M; Gouveia, MINTRODUCTION AND OBJECTIVES:Recently, three novel non-vitamin K antagonist oral anticoagulants received approval for reimbursement in Portugal for patients with non-valvular atrial fibrillation (AF). It is therefore important to evaluate the relative cost-effectiveness of these new oral anticoagulants in Portuguese AF patients. METHODS: A Markov model was used to analyze disease progression over a lifetime hori...